ES2174756B2 - Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias. - Google Patents

Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.

Info

Publication number
ES2174756B2
ES2174756B2 ES200100817A ES200100817A ES2174756B2 ES 2174756 B2 ES2174756 B2 ES 2174756B2 ES 200100817 A ES200100817 A ES 200100817A ES 200100817 A ES200100817 A ES 200100817A ES 2174756 B2 ES2174756 B2 ES 2174756B2
Authority
ES
Spain
Prior art keywords
treatment
derivatives
respiratory diseases
azolilcarbinoles
heteroaril
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES200100817A
Other languages
English (en)
Other versions
ES2174756A1 (es
Inventor
Ramon Merce-Vidal
Blas Andaluz-Matero
Jordi Frigola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to ES200100817A priority Critical patent/ES2174756B2/es
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Priority to IL15826802A priority patent/IL158268A0/xx
Priority to ES02714232T priority patent/ES2236497T3/es
Priority to PCT/ES2002/000136 priority patent/WO2002080908A1/es
Priority to RU2003132456/15A priority patent/RU2294198C2/ru
Priority to PL02365251A priority patent/PL365251A1/xx
Priority to CA002443015A priority patent/CA2443015A1/en
Priority to CNB028098943A priority patent/CN1230165C/zh
Priority to MXPA03009125A priority patent/MXPA03009125A/es
Priority to AU2002246151A priority patent/AU2002246151B2/en
Priority to PT02714232T priority patent/PT1384476E/pt
Priority to KR10-2003-7013063A priority patent/KR20040025913A/ko
Priority to US10/474,232 priority patent/US20040142994A1/en
Priority to AT02714232T priority patent/ATE289812T1/de
Priority to NZ529303A priority patent/NZ529303A/en
Priority to DK02714232T priority patent/DK1384476T3/da
Priority to DE60203106T priority patent/DE60203106T2/de
Priority to HU0400925A priority patent/HUP0400925A3/hu
Priority to EP02714232A priority patent/EP1384476B1/en
Priority to BR0208807-0A priority patent/BR0208807A/pt
Priority to JP2002578947A priority patent/JP2004531511A/ja
Publication of ES2174756A1 publication Critical patent/ES2174756A1/es
Priority to NO20034471A priority patent/NO20034471L/no
Priority to ZA200308630A priority patent/ZA200308630B/en
Application granted granted Critical
Publication of ES2174756B2 publication Critical patent/ES2174756B2/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de enfermedades respiratorias. Los derivados de aril(o heteroaril)azolilcarbinoles de fórmula general (I), en la cual Ar representa un radical fenilo o un radical tienilo, opcionalmente sustituidos, R1 representa un átomo de hidrógeno o un grupo alquilo inferior, R2 representa un radical dialquilaminoalquilo o azaheterociclilalquil y Het representa un azol no sustituido u opcionalmente sustituido por uno o dos sustituyentes, así como sus sales fisiológicamente aceptables; son útiles como medicamentos en terapéutica humana y/o veterinaria para el tratamiento de enfermedades respiratorias especialmente para el tratamiento de la tos, bronquitis, enfermedades pulmonares obstructivas crónicas, rinitis alérgica y asma.
ES200100817A 2001-04-06 2001-04-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias. Expired - Fee Related ES2174756B2 (es)

Priority Applications (23)

Application Number Priority Date Filing Date Title
ES200100817A ES2174756B2 (es) 2001-04-06 2001-04-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
AT02714232T ATE289812T1 (de) 2001-04-06 2002-03-21 Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen
PCT/ES2002/000136 WO2002080908A1 (es) 2001-04-06 2002-03-21 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias
RU2003132456/15A RU2294198C2 (ru) 2001-04-06 2002-03-21 Производные арил(или гетероарил)азолилкарбинола для лечения респираторных заболеваний
PL02365251A PL365251A1 (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
CA002443015A CA2443015A1 (en) 2001-04-06 2002-03-21 Aryl (or heteroaryl) azolylcarbinole derivatives for the treatment of respiratory diseases
CNB028098943A CN1230165C (zh) 2001-04-06 2002-03-21 治疗呼吸疾病的芳基(或杂芳基)氮杂茂基甲醇衍生物
MXPA03009125A MXPA03009125A (es) 2001-04-06 2002-03-21 Derivados de aril (o heteroaril), azolilcarbinoles para el tratamiento de enfermedades respiratorias.
AU2002246151A AU2002246151B2 (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
PT02714232T PT1384476E (pt) 2001-04-06 2002-03-21 Derivados azolilcarbinol de arilo (ou heteroarilo) para o tratamento de doencas respiratorias
KR10-2003-7013063A KR20040025913A (ko) 2001-04-06 2002-03-21 호흡기 질환의 치료를 위한 아릴(또는 헤테로아릴)아졸릴카르비놀 유도체
DK02714232T DK1384476T3 (da) 2001-04-06 2002-03-21 Azolylcarbinolderivater af aryl (eller heteroaryl) til behandling af åndedrætssygdomme
IL15826802A IL158268A0 (en) 2001-04-06 2002-03-21 Azolylcarbinol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
NZ529303A NZ529303A (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
US10/474,232 US20040142994A1 (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
DE60203106T DE60203106T2 (de) 2001-04-06 2002-03-21 Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen
HU0400925A HUP0400925A3 (en) 2001-04-06 2002-03-21 Azolycarbynol derivatives of aryl (or heteroaryl) for producing pharmaceutical compositions for the treatment of respiratory diseases
EP02714232A EP1384476B1 (en) 2001-04-06 2002-03-21 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases
BR0208807-0A BR0208807A (pt) 2001-04-06 2002-03-21 Uso de uma arila um derivado de (heterolaril) azolilcarbinole e composição farmacêutica
ES02714232T ES2236497T3 (es) 2001-04-06 2002-03-21 Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de enfermedades respiratorias.
JP2002578947A JP2004531511A (ja) 2001-04-06 2002-03-21 呼吸器疾患治療用アリール（又はヘテロアリール）アゾリルカルビノール誘導体
NO20034471A NO20034471L (no) 2001-04-06 2003-10-06 Aryl (eller heteroaryl)-azolylkarbinolderivater for behandling av respiratoriske sykdommer
ZA200308630A ZA200308630B (en) 2001-04-06 2003-11-05 Azolylcarbynol derivatives of aryl (or heteroaryl) for the treatment of respiratory diseases.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200100817A ES2174756B2 (es) 2001-04-06 2001-04-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.

Publications (2)

Publication Number Publication Date
ES2174756A1 ES2174756A1 (es) 2002-11-01
ES2174756B2 true ES2174756B2 (es) 2003-11-16

Family

ID=8497368

Family Applications (2)

Application Number Title Priority Date Filing Date
ES200100817A Expired - Fee Related ES2174756B2 (es) 2001-04-06 2001-04-06 Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
ES02714232T Expired - Lifetime ES2236497T3 (es) 2001-04-06 2002-03-21 Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de enfermedades respiratorias.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02714232T Expired - Lifetime ES2236497T3 (es) 2001-04-06 2002-03-21 Derivados de aril(o heteroaril)azolilcarbinoles para el tratamiento de enfermedades respiratorias.

Country Status (22)

Country Link
US (1) US20040142994A1 (es)
EP (1) EP1384476B1 (es)
JP (1) JP2004531511A (es)
KR (1) KR20040025913A (es)
CN (1) CN1230165C (es)
AT (1) ATE289812T1 (es)
AU (1) AU2002246151B2 (es)
BR (1) BR0208807A (es)
CA (1) CA2443015A1 (es)
DE (1) DE60203106T2 (es)
DK (1) DK1384476T3 (es)
ES (2) ES2174756B2 (es)
HU (1) HUP0400925A3 (es)
IL (1) IL158268A0 (es)
MX (1) MXPA03009125A (es)
NO (1) NO20034471L (es)
NZ (1) NZ529303A (es)
PL (1) PL365251A1 (es)
PT (1) PT1384476E (es)
RU (1) RU2294198C2 (es)
WO (1) WO2002080908A1 (es)
ZA (1) ZA200308630B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335566A1 (de) * 2003-07-31 2005-02-24 Grünenthal GmbH Arzneimittel enthaltend Derivate von Aryl( oder Heteroaryl)azolylcarbinolen
EP1584335A3 (en) * 2004-04-05 2006-02-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising a carbinol composition and an opioid
ES2244326B1 (es) * 2004-04-05 2007-02-16 Laboratorios Del Dr. Esteve, S.A. Combinacion de substancias activas.
EP1784178A1 (en) * 2004-07-30 2007-05-16 Laboratorios Del Dr. Esteve, S.A. Aryl (or heteroaryl) azolylcarbinols
EP1632227A1 (en) * 2004-09-07 2006-03-08 Laboratorios del Dr. Esteve S.A. Derivatives of aryl (or heteroaryl) azolylcarbinols (in particular cizolirtin citrate) for the treatment of opioid addiction
EP1820502A1 (en) * 2006-02-10 2007-08-22 Laboratorios Del Dr. Esteve, S.A. Active substance combination comprising azolylcarbinol compounds
WO2010123999A2 (en) * 2009-04-21 2010-10-28 Auspex Pharmaceuticals, Inc. 1-methylpyrazole modulators of substance p, calcitonin gene-related peptide, adrenergic receptor, and/or 5-ht receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2150353B1 (es) * 1998-04-15 2001-07-01 Esteve Labor Dr Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos.
ES2137136B1 (es) * 1998-05-18 2000-07-01 Esteve Labor Dr Empleo de derivados de aril (o heteroaril) azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de la inflamacion neurogenica.
ES2150378B1 (es) * 1998-08-07 2001-07-01 Esteve Labor Dr Empleo de derivados de aril(o heteroaril)azolilcarbinoles en la elaboracion de un medicamento para el tratamiento de los trastornos mediados por un exceso de substancia p.

Also Published As

Publication number Publication date
JP2004531511A (ja) 2004-10-14
PL365251A1 (en) 2004-12-27
RU2003132456A (ru) 2005-04-10
NO20034471D0 (no) 2003-10-06
HUP0400925A2 (hu) 2004-07-28
ATE289812T1 (de) 2005-03-15
ES2236497T3 (es) 2005-07-16
DK1384476T3 (da) 2005-05-30
BR0208807A (pt) 2004-07-13
PT1384476E (pt) 2005-05-31
RU2294198C2 (ru) 2007-02-27
WO2002080908A1 (es) 2002-10-17
KR20040025913A (ko) 2004-03-26
CN1535147A (zh) 2004-10-06
NZ529303A (en) 2005-06-24
EP1384476B1 (en) 2005-03-02
CA2443015A1 (en) 2002-10-17
EP1384476A1 (en) 2004-01-28
MXPA03009125A (es) 2005-04-11
AU2002246151B2 (en) 2007-05-31
CN1230165C (zh) 2005-12-07
AU2002246151C1 (en) 2002-10-21
DE60203106D1 (de) 2005-04-07
ES2174756A1 (es) 2002-11-01
IL158268A0 (en) 2004-05-12
NO20034471L (no) 2003-12-03
HUP0400925A3 (en) 2004-10-28
US20040142994A1 (en) 2004-07-22
DE60203106T2 (de) 2006-04-13
ZA200308630B (en) 2004-11-05

Similar Documents

Publication Publication Date Title
EA201290260A1 (ru) Бензимидазол-имидазольные производные
PE20161066A1 (es) Derivados de piperidinil-indol como inhibidores del factor de complemento b y usos de los mismos
ECSP045367A (es) "derivados de bencimidazol utiles como antagonistas de histamina h3"
CY1110392T1 (el) Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης
CY1122201T1 (el) Παραγωγα βενζοδιοξολιου ως αναστολεις φωσφοδιεστερασης
CO6341631A2 (es) Derivados de 1,2,4 - oxadiazol y su uso terapéutico
EA201170099A1 (ru) Замещенные пиримидин-4-оновые производные
UY30842A1 (es) Derivados de n-(amino-heteroaril)-1h-pirrolopiridin-2-carboxamidas, su preparacion y su aplicacion en terapéutica
NO20092770L (no) Nye aminopyrimidinderivater som PLK1-inhibitorer
PE20160540A1 (es) Inhibidores de bromodominios
CY1117080T1 (el) Θεραπευτικος παραγοντας για στενωση του σπονδυλικου σωληνα
MX2013004407A (es) Derivado de piridina y agente medicinal.
NO20071137L (no) Nye piperidinderivater for behandling av depresjon
ES2180449B1 (es) Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de la incontinencia urinaria.
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
JO3261B1 (ar) مشتق بيريدين أحادي الحلقة
WO2009095792A3 (en) Substituted heteroarylamide diazepinopyrimidone derivatives
EA201170098A1 (ru) Замещенные производные алкилпиримидин-4-она
MX2010008360A (es) Derivados de oxazepinopirimidona heteroarilamida sustituidos.
EA201071012A1 (ru) Производные азетидинов, способ их получения и применение их в терапии
EA201171385A1 (ru) Производные циклопента[с]пирролилалкилкарбаматов 5-членных гетероциклов, способ их получения и применение их в терапии
ATE521609T1 (de) Aminothiazolylpyrimidinderivate und ihre verwendung bei der behandlung von krebs
ES2174756B2 (es) Derivados de aril (o heteroaril) azolilcarbinoles para el tratamiento de enfermedades respiratorias.
ATE524181T1 (de) Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
TW200607805A (en) Novel pyridazinone derivatives, methods for producing them and their use as pharmaceuticals

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20021101

Kind code of ref document: A1

Effective date: 20021101

FG2A Definitive protection

Ref document number: 2174756B2

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20170216